Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam

Neuropsychiatric Disease and Treatment

Volumn 2, Issue 2, 2006, Pages 235-240

  Yacoub, Adeeb ^a   Francis, Andrew ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Atypical antipsychotics; Catatonia; Lorazepam; Neuroleptic malignant syndrome; Rating scale

Indexed keywords

ALANINE AMINOTRANSFERASE; ARIPIPRAZOLE; ASPARTATE AMINOTRANSFERASE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; CLOZAPINE; CREATINE KINASE; LORAZEPAM; OLANZAPINE; PARACETAMOL; PERPHENAZINE; QUETIAPINE; TIOTIXENE; TRAZODONE; VALPROATE SEMISODIUM;

ADULT; AGED; AGGRESSIVENESS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTONOMIC DYSFUNCTION; BEHAVIOR DISORDER; BIPOLAR DISORDER; BLOOD PRESSURE VARIABILITY; BRAIN ATROPHY; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL FEATURE; CONFUSION; CONSCIOUSNESS DISORDER; CREATINE KINASE BLOOD LEVEL; DEMENTIA; DIAPHORESIS; DRUG FEVER; DRUG RESPONSE; DRUG WITHDRAWAL; ENZYME DEFECT; FATIGUE; GAIT DISORDER; HUMAN; LEUKOCYTOSIS; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PARANOIA; PATIENT CARE; PULSE RATE; RATING SCALE; RESTLESSNESS; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SENSORY DYSFUNCTION; SOMNOLENCE; SWEAT GLAND DISEASE; TACHYPNEA; TREMOR; URINE INCONTINENCE;

EID: 33745898804     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/nedt.2006.2.2.235     Document Type: Article

References (13)

1. [APA] American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. APA.
2. Caroff SN, Mann SC. 1993. Neuroleptic malignant syndrome. Med Clin North Am, 77:185-202.
3. Caroff SN, Mann SC, Campbell EC. 2000. Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Ann, 30:314-21.
4. Caroff SN. 2003. Neuroleptic malignant syndrome [Still a risk but which patient may be in danger?]. Curr Psychiatr, 12:36-42.
5. Davis JM, Caroff SN, Mann SC. 2000. Treatment of neuroleptic malignant syndrome. Psychiatr Ann, 30:325-31.
6. Fink M. 1996. Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry, 39:1-4.
7. Francis A, Chandragiri S, Rizivi S, et al. 2000. Lorazepam a treatment of neuroleptic malignant syndrome? CNS Spectr, 5:54-7.
8. Hynes A, Victar E. 1996. Case study:neuroleptic malignant syndrome without pyrexia. J Am Acad Child Adolesc Psychiatry, 35:959-61.
9. Khaldarov V. 2000. Benzodiazepines as treatment for neuroleptic malignant syndrome. Hosp Physician, 6:51-5.
10. Levenson JL. 1985. Neuroleptic malignant syndrome. Am J Psychiatry, 142:1137-45.
11. Miyaoko H, Shishikura K, Otsubo T, et al. 1997. Diazepam-responsive neuroleptic malignant syndrome: a diagnostic subtype? Am J Psychiatry, 1997:154:882.
12. Sachdev P, Kruk J, Kneebone M, et al. 1995. Clozapine induced neuroleptic malignant syndrome: review and report of new cases. J Clin Psychopharmacol, 15:365-71.
13. Yacoub A, Kohen I, Caraballo A, et al. 2004. Rating Scale of Neuroleptic Malignant Syndrome [poster]. American Psychiatric Association. May 2004. poster 684.